How did CTS Corporation (CTS) raise its 2026 outlook after higher margins?

Sonal Goyal

28 October 2026 05:16 PM AEDT

How did CTS Corporation (CTS) raise its 2026 outlook after higher margins?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

CTS reported third-quarter 2026 sales of $149.6 million, up 5 per cent, with adjusted Diluted Earnings per Share of $0.77 against $0.60.
Adjusted gross Margin rose to 42.2 per cent from 38.9 per cent, and free Cash Flow was $41.1 million.
The company raised 2026 guidance to sales of $580 million to $590 million and adjusted diluted earnings per share of $2.78 to $2.88.

Third-quarter results

CTS Corporation (NYSE:CTS) reported third-quarter 2026 results on 27 October 2026. Sales were $149.6 million, up 5 per cent from $143.0 million a year earlier. Sales to diversified end markets rose 7 per cent and now make up 60 per cent of the total, while transportation sales rose 2 per cent.

GAAP Net Income was $17.8 million, or 11.9 per cent of sales, compared with $13.7 million in the third quarter of 2025. GAAP diluted earnings per share were $0.61, against $0.46. Adjusted diluted earnings per share were $0.77, against $0.60.

Earnings grew faster than sales. Adjusted earnings per share rose about 28 per cent on sales growth of 5 per cent, helped by a wider adjusted gross margin and a higher adjusted EBITDA margin. That pattern points to mix and cost effects rather than Volume alone.

Margins and one-off items

GAAP operating earnings were $25.5 million, a 17.1 per cent margin, while the adjusted Operating Margin was 18.4 per cent. Adjusted gross margin rose to 42.2 per cent from 38.9 per cent. Adjusted EBITDA was $37.0 million, a 24.7 per cent margin, compared with 23.8 per cent a year earlier.

GAAP net income included a $12.5 million insurance recovery recorded in other income and a $12.7 million discrete tax benefit. The company excludes both from its adjusted results, so the adjusted figures are the better guide to underlying performance, although they remain non-GAAP measures.

Cash generation

Operating cash flow was $43.5 million, up from $29.0 million, and free cash flow was $41.1 million, up from $24.2 million. Capital Expenditure was only $2.4 million. Free cash flow exceeded both GAAP net income and adjusted EBITDA, which may reflect working-capital timing.

The release did not disclose backlog, and it gave no formal segment results beyond the split between diversified and transportation markets. Treasury stock rose by about $15.4 million since the end of 2025, but the release does not say whether that reflects share repurchases.

Raised full-year guidance

CTS raised its 2026 guidance. Sales are now expected to be $580 million to $590 million, up from $565 million to $585 million. Adjusted diluted earnings per share are expected to be $2.78 to $2.88, up from $2.55 to $2.70. These are management forecasts, not reported results, and the company did not provide fourth-quarter-specific guidance.

Chief Executive Pratik Trivedi attributed the results to disciplined execution, citing profitable growth, higher margins and cash generation. The release also said the Millar Acquisition advances the company's diversification, particularly in medical markets, though it gave no price, closing date or financial details.

The guidance revision therefore relies more on profitability than on revenue, which is consistent with the margin gains reported in the quarter.

What to watch

Items to follow include delivery against the raised guidance, the diversified share of sales, the contribution from Millar once disclosed, and whether the quarter's cash conversion continues.

FAQs

Q: What were CTS Corporation's third-quarter 2026 sales?

A: Sales were $149.6 million, up 5 per cent from $143.0 million a year earlier. Diversified end markets rose 7 per cent and now account for 60 per cent of sales.

Q: How did CTS change its 2026 guidance?

A: Sales guidance was raised to $580 million to $590 million from $565 million to $585 million. Adjusted diluted earnings per share guidance was raised to $2.78 to $2.88 from $2.55 to $2.70.

Q: What one-off items affected CTS's GAAP net income?

A: GAAP net income included a $12.5 million insurance recovery and a $12.7 million discrete tax benefit. The company excludes both from adjusted results.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.